These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2793836)

  • 1. Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons.
    Ratey JJ; Sovner R; Mikkelsen E; Chmielinski HE
    J Clin Psychiatry; 1989 Oct; 50(10):382-4. PubMed ID: 2793836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buspirone treatment of aggression and anxiety in mentally retarded patients: a multiple-baseline, placebo lead-in study.
    Ratey J; Sovner R; Parks A; Rogentine K
    J Clin Psychiatry; 1991 Apr; 52(4):159-62. PubMed ID: 2016248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buspirone for autistic disorder in a woman with an intellectual disability.
    Brahm NC; Fast GA; Brown RC
    Ann Pharmacother; 2008 Jan; 42(1):131-7. PubMed ID: 18056831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta adrenergic blocking medications for aggressive or self-injurious mentally retarded persons.
    Ruedrich SL; Grush L; Wilson J
    Am J Ment Retard; 1990 Jul; 95(1):110-9. PubMed ID: 1974768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of buspirone on challenging behaviour in mentally retarded patients: an open prospective multiple-case study.
    Verhoeven WM; Tuinier S
    J Intellect Disabil Res; 1996 Dec; 40 ( Pt 6)():502-8. PubMed ID: 9004110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buspirone's efficacy in organic-induced aggression.
    Stanislav SW; Fabre T; Crismon ML; Childs A
    J Clin Psychopharmacol; 1994 Apr; 14(2):126-30. PubMed ID: 8195453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and usefulness of buspirone as an anxiolytic drug in elderly versus young patients.
    Robinson D; Napoliello MJ; Schenk J
    Clin Ther; 1988; 10(6):740-6. PubMed ID: 3219687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buspirone in the long-term treatment of generalized anxiety disorder.
    Feighner JP
    J Clin Psychiatry; 1987 Dec; 48 Suppl():3-6. PubMed ID: 3320034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of adjustment disorder with anxiety: efficacy and tolerance of etifoxine in a double-blind controlled study].
    Servant D; Graziani PL; Moyse D; Parquet PJ
    Encephale; 1998; 24(6):569-74. PubMed ID: 9949940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective study of lithium use for institutionalized mentally retarded individuals with behavior disorders.
    Langee HR
    Am J Ment Retard; 1990 Jan; 94(4):448-52. PubMed ID: 2105098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maladaptive behaviors associated with neuroleptic drug maintenance.
    Chadsey-Rusch J; Sprague RL
    Am J Ment Retard; 1989 May; 93(6):607-17. PubMed ID: 2566315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium and propranolol in aggression and self-injurious behavior in the mentally retarded.
    Luchins DJ; Dojka D
    Psychopharmacol Bull; 1989; 25(3):372-5. PubMed ID: 2626515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of self-injurious behavior and other maladaptive behaviors among individuals with severe and profound intellectual disability.
    Matson JL; Cooper C; Malone CJ; Moskow SL
    Res Dev Disabil; 2008; 29(2):141-8. PubMed ID: 17350800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effects of buspirone on intractable self-injury in adults with mental retardation.
    Ricketts RW; Goza AB; Ellis CR; Singh YN; Chambers S; Singh NN; Cooke JC
    J Am Acad Child Adolesc Psychiatry; 1994 Feb; 33(2):270-6. PubMed ID: 8150800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and prediction of psychotropic drug use in California developmental centers.
    Stone RK; Alvarez WF; Ellman G; Hom AC; White JF
    Am J Ment Retard; 1989 May; 93(6):627-32. PubMed ID: 2719845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of clozapine in a mentally retarded and aggressive population.
    Cohen SA; Underwood MT
    J Clin Psychiatry; 1994 Oct; 55(10):440-4. PubMed ID: 7961521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azapirones: an alternative to benzodiazepines for anxiety.
    Cadieux RJ
    Am Fam Physician; 1996 May; 53(7):2349-53. PubMed ID: 8638511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and fluoxetine treatment of compulsive behavior disorder of adults with mental retardation.
    Bodfish JW; Madison JT
    Am J Ment Retard; 1993 Nov; 98(3):360-7. PubMed ID: 8292312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buspirone hydrochloride in the treatment of transvestic fetishism.
    Fedoroff JP
    J Clin Psychiatry; 1988 Oct; 49(10):408-9. PubMed ID: 3271001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.